Mature B-cell Non-Hodgkin Lymphomas in Children and Young Adults: The Same Diseases as in Adults or Distinct Entities?
Authors:
Ludvík Kašpar; Daniela Hamaňová; Vít Campr; Josef Zámečník
Authors‘ workplace:
Ústav patologie a molekulární medicíny, 2. LF UK a FN Motol, Praha
Published in:
Čes.-slov. Patol., 62, 2026, No. 3, p. 208-211
Category:
Original Article
Overview
Mature B-cell non-Hodgkin lymphomas (B-NHL) represent a significant group of malignancies in both children and adults. In pediatric oncology, they rank third among the most common cancers. Although many entities occur in both age groups, pediatric cases often display distinct biological, morphological, and clinical features compared with adults. This review focuses on the major types of mature B-NHL in children – Burkitt lymphoma, diffuse large B-cell lymphoma, and primary mediastinal B-cell lymphoma – with particular attention to their differences between pediatric and adult patients. The aim of the article is to summarize current knowledge in this dynamically evolving field and to outline potential directions for future research and classification of these diseases.
Keywords:
Diffuse large B-cell lymphoma – Pediatric oncology – Burkitt lymphoma – pediatric lymphoma – primary mediastinal B-cell lymphoma
Sources
1. Czech Childhood Cancer Information System (CCCIS). Ústav zdravotnických informací a statistiky ČR. Dostupné z: https://ccc-is.uzis.cz.
2. Krejčí D, Zdražilová Dubská L, Vrtěl R, a kol. Nádory lymfatického systému u dětí a mladistvých v České republice 1994–2016. Praha: Ústav zdravotnických informací a statistiky ČR; 2019. Dostupné z: https://ccc-is. uzis.cz/res/file/analyzy/iccc-ii.pdf.
3. Kooperativní lymfomová skupina (Czech Lymphoma Study Group). Léčebná doporučení pro diagnostiku a terapii lymfomů. Praha: KLS; 2022. Dostupné z: https://www.lymphoma.cz/_uploads/attachments/Lecebna_doporuceni_06-JAN-2022.pdf.
4. WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon: International Agency for Research on Cancer; 2024. (WHO Classification of Tumours series, 5th ed., vol. 11). Dostupné z: https://publications.iarc.who.int/637
5. Xavier AC, Attarbaschi A, Gratzinger D, Balagué O. Dedicated diagnostic approaches for mature B-cell non-Hodgkin lymphomas occurring in children, adolescents, and young adults. Histopathology 2025;86 : 17–37.
6. Hochberg J, Flower A, Brugieres L, Cairo MS. NHL in adolescents and young adults: a unique population. Pediatr Blood Cancer 2018;65:e27073.
7. El-Mallawany NK, Giulino-Roth L, Burke JM, Hermiston M, Allen CE. Mature B-cell lymphomas in adolescents and young adults. eJHaem 2023;4 : 912–920.
8. Dilmurat D, Wang X, Gao L, Jiao T, Ai J, Li Z, et al. Clinical epidemiology of Epstein - -Barr virus-associated lymphoproliferative disorders in hospitalized children: a six-year multi-institutional study in China. Ital J Pediatr 2024;50(1).
9. Clybouw C, Mchichi B, Mouhamad S, Auffredou M, Bourgeade M, Sharma S, et al. EBV infection of human B lymphocytes leads to down-regulation of BIM expression: relationship to resistance to apoptosis. J Immunol 2005;175(5):2968–2973.
10. Ok CY, Li L, Xu-Monette ZY, et al. Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res 2014;20(9):2338–2349.
11. Bourbon E, Maucort-Boulch D, Fontaine J, et al. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified. Blood Adv 2021;5(16):3227–3239.
12. Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol 2019;9 : 713.
13. Hashemieh M, Shirvani F. Epstein-Barr virus - -associated pediatric neoplasms. Arch Pediatr Infect Dis 2020;8(1).
14. Herber M, Mertz P, Dieudonné Y, Guffroy B, Jung S, Gies V, et al. Primary immunodeficiencies and lymphoma: a systematic review of literature. Leuk Lymphoma 2020;61(2):274–284.
15. Costagliola G, Marco E, Massei F, Roberti G, Catena F, Casazza G, et al. The etiologic landscape of lymphoproliferation in childhood: proposal for a diagnostic approach. Ther Clin Risk Manag 2024;20 : 261–274.
16. Smedby KE, Ponzoni M. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J Intern Med 2017;282(5):360–370.
17. Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014;2014(48):130–144.
18. Al-Khreisat MJ, Ismail NH, Tabnjh A, Hussain FA, Mohamed Yusoff AA, Johan MF, et al. Worldwide prevalence of Epstein–Barr virus in patients with Burkitt lymphoma: a systematic review and meta-analysis. Diagnostics 2023;13(12):2068.
19. Linch DC. Burkitt lymphoma in adults. Br J Haematol 2012;156(6):693–703.
20. Grande BM, Gerhard DS, Jiang A, et al. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 2019;133(12):1313–1324.
21. Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, et al. Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol 2022;196(3):681–689.
22. Rochford R. Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants. Ann Lymphoma 2021;5 : 22.
23. Thomas N, Dreval K, Gerhard DS, Morin RD, et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood 2023;141(8):904–916.
24. Lange J, Lenz G, Burkhardt B. Mature aggressive B-cell lymphoma across age groups: molecular advances and therapeutic implications. Expert Rev Hematol 2017;10(2):123 – 135.
25. Choi JK, Quintanilla-Martinez L. Pediatric lymphomas: overview and diagnostic challenges. Virchows Arch 2025;486 : 81–100.
26. Szczepanowski M, Lange J, Kohler CW, Masque-Soler N, Zimmermann M, Aukema SM, et al. Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents. Br J Haematol 2017;179 : 116–119
27. Poirel H, Cairo MS, Heerema NA, et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin‘s lymphoma: results of the FAB/LMB 96 international study. Leukemia 2009;23(2):323–331.
28. Klapper W, Szczepanowski M, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 2008;112(4):1374–1381.
29. Klapper W, Kreuz M, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood 2012;119(8):1882 – 1887.
30. Savage KJ. Primary mediastinal large B-cell lymphoma. Blood 2022;140(9):955–970.
31. Zhou H, Liu Q, Zou L, et al. Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival. Ann Hematol 2023;102(7):1879 – 1886.
32. Oschlies I, Burkhardt B, Klapper W, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica 2011;96(2):262–268.
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
2026 Issue 3
-
All articles in this issue
- Léky indukované změny v histopatologii
- Setkání s každým člověkem je obohacující…
- MONITOR aneb nemělo by vám uniknout, že...
- Iatrogenic injury of the gastrointestinal tract
- Morphological aspects of drug-induced cutaneous reactions
- Drug induced and toxic liver injury
- Drug-Induced Nephropathies from the Pathologist‘s Perspective
- Immunotherapy Adverse Events in the Treatment of Solid Tumors
- Mature B-cell Non-Hodgkin Lymphomas in Children and Young Adults: The Same Diseases as in Adults or Distinct Entities?
- Pseudomyogenic hemangioendothelioma
- Czecho-Slovak Pathology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Drug induced and toxic liver injury
- Léky indukované změny v histopatologii
- Morphological aspects of drug-induced cutaneous reactions
- Setkání s každým člověkem je obohacující…